PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye.
With the PolyActiva technology, exceptional zero-order release profiles are achieved over treatment periods ranging from 6 to 12 months.
Our mission is to become a leader in ophthalmic medicine by providing unique biodegradable implants with sustained drug delivery to improve patient outcomes and quality of life.
-
Industry
-
Biotechnology Research
-
Company size
-
11-50 employees
-
Headquarters
-
Melbourne, VIC
-
Type
-
Privately Held
-
Founded
-
2010
-
Specialties
-
Polymer Chemistry, Drug Delivery, and Ophthalmology